Evidence map›Paper›PMID 22881604›Full record

ArticleAnalytical chemistry2012

Development of a peptidase-resistant substrate for single-cell measurement of protein kinase B activation.

Angela Proctor, Qunzhao Wang, David S Lawrence, Nancy L Allbritton

Abstract read
In one paragraph

Article in Analytical chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Angela ProctorDepartment of Chemistry, University of North Carolina, Chapel Hill, North Carolina 27599, USA.
Qunzhao Wang
David S Lawrence
Nancy L Allbritton

Funding

SYNTHETIC REGULATORS OF TYROSINE PROTEIN KINASESR01CA079954 · NCI · YESHIVA UNIVERSITY · PI LAWRENCE, DAVID S. · 1999 to 2016
$4.2M
Multiplexed Measurement of Kinase Activity in Single Cancer CellsR01CA139599 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ALLBRITTON, NANCY L. · 2009 to 2013
$2.7M
Signaling Network Dynamics in Metastatic Prostate CancerR01CA140173 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LAWRENCE, DAVID S. · 2009 to 2013
$2.0M
NCI NIH HHS CA139599NCI NIH HHS CA140173NCI NIH HHS R01 CA139599NCI NIH HHS R01 CA140173
6 · The paper itself

Abstract

An iterative design strategy using three criteria was utilized to develop a peptidase-resistant substrate peptide for protein kinase B. Libraries of peptides possessing non-native amino acids were screened for time to 50% phosphorylation, degradation half-life within a lysate, and appearance of a dominant fragment. The lead peptide possessed a half-life of 92 ± 7 and 16 ± 2 min in HeLa and LNCaP cytosolic lysates, respectively, representing a 4.6- and 2.7-fold lifetime improvement over that of the starting peptide. The redesigned peptide possessed a 4.5-fold improvement in phosphorylation efficiency compared to the starting peptide. The same peptide fragments were formed when the lead peptide was incubated in a lysate or loaded into single cells although the fragments formed in significantly different ratios suggesting that distinct peptidases metabolized the peptide in the two preparations. The rate of peptide degradation and phosphorylation was on average 0.1 ± 0.2 zmol pg(-1) s(-1) and 0.04 ± 0.08 zmol pg(-1) s(-1), respectively, for single LNCaP cells loaded with 4 ± 8 μM of peptide. Peptidase-resistant kinase substrates should find widespread utility in both lysate-based and single-cell assays of kinase activity.

Indexed as

Drug DesignSingle-Cell AnalysisAmino Acid SequenceAmino Acid SubstitutionArginineCytosolEnzyme ActivationHeLa CellsHumansOligopeptidesPeptide HydrolasesPhosphorylationProtein BindingProtein Kinase InhibitorsProteolysisProto-Oncogene Proteins c-aktArginineOligopeptidesPeptide HydrolasesProtein Kinase InhibitorsProto-Oncogene Proteins c-akt

Identifiers

PMID22881604
PMCPMC3428732

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.